111
People may suffer ‘long colds’ more than four weeks after infection, study shows | Medical research
(www.theguardian.com)
This is for strictly mildly interesting material. If it's too interesting, it doesn't belong. If it's not interesting, it doesn't belong.
This is obviously an objective criteria, so the mods are always right. Or maybe mildly right? Ahh.. what do we know?
Just post some stuff and don't spam.
Thanks for the well wishes. Also last year I participated in a clinical trial with this same team at the Brigham. The drug trialed there is called bocidelpar. It targets a mitochondrial receptor called PPAR-δ. We're still waiting on the results of that trial to be released and it's probably a good 3-5 years away from FDA approval in the US if all goes well. So here's hoping for the best